PSA is produced by prostate tissue, both healthy and cancerous. More prostate tissue, or irritated prostate tissue, means more PSA. That is why the test is imprecise: it measures prostate activity, not cancer.
The normal range rises with age, because the prostate enlarges with age. Broad reference points used in UK practice: under 3.0 for men in their fifties, under 4.0 in their sixties, and higher thresholds above that. Interpretation against your age matters, and a single number without that context is close to meaningless.
Causes of a raised PSA other than cancer: benign prostatic hyperplasia, which is the commonest by far; urinary infection or prostatitis; recent ejaculation; vigorous exercise, especially cycling; a recent catheter or prostate procedure; and simply having a large prostate.
What actually happens with a raised result. The usual next step is not a biopsy. It is repeating the test, because a substantial proportion of raised PSAs normalise on repeat, particularly where infection or exercise was a factor. Where it remains raised, current UK practice uses an MRI scan before biopsy, which has substantially reduced unnecessary biopsies and is a genuine improvement on how this used to be done.
The honest account of the trade offs, which is the part most pages omit:
- In favour: prostate cancer is common, it is very treatable when localised, and PSA testing does reduce deaths from it to some degree.
- Against: PSA misses a meaningful proportion of cancers, so a normal result is not a clean bill of health. It flags many men who do not have cancer, causing anxiety and investigation. And it detects slow growing cancers that would never have caused symptoms in a man’s lifetime, and treating those causes incontinence and erectile dysfunction in some men who were never at risk.
- Which is why the UK has no screening programme, and why the decision to test is genuinely yours to make with information rather than a straightforward yes.
On active surveillance. Worth knowing before you test: many low-risk prostate cancers are now monitored rather than treated, precisely because treatment can do more harm than the cancer would. A diagnosis does not automatically mean surgery or radiotherapy.